参考文献:1. Heeringa, J., Kuip, D.A.M., Hofman, A. (2006) Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 27: pp. 949-953 CrossRef 2. Fuster, V., Ryden, L.E., Cannom, D.S. (2006) ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114: pp. e257-354 CrossRef 3. Camm, A.J., Kirchhof, P., Lip, G.Y.H. (2010) Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 31: pp. 2369-2429 CrossRef 4. Camm, A.J., Lip, G.Y.H., Caterina, R. (2012) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 33: pp. 2719-2747 CrossRef 5. Singer, D.E., Chang, Y., Fang, M.C. (2009) The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 151: pp. 297-305 CrossRef 6. Mant, J., Hobbs, F.D.R., Fletcher, K. (2007) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370: pp. 493-503 CrossRef 7. Rash, A., Downes, T., Portner, R. (2007) A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 36: pp. 151-156 CrossRef 8. Ogilvie, I.M., Newton, N., Welner, S.A. (2010) Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 123: pp. 638-645 CrossRef 9. Becquemont, L., Benattar-Zibi, L., Bertin, P. (2013) National observatory on the therapeutic management in ambulatory care patients aged 65 and over, with type 2 diabetes, chronic pain or atrial fibrillation. Therapie 68: pp. 265-283 CrossRef 10. Folstein, M.F., Folstein, S.E., McHugh, P.R. (1975) 芦Mini-mental state禄. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: pp. 189-198 CrossRef 11. Katz, S., Ford, A.B., Moscowitz, R.W. (1963) Studies of Illness in the Age. The index of ADL: a Standardized Measure of the Biological and Psychosocial Function. JAMA 185: pp. 914-919 CrossRef 12. Lawton, M.P., Brody, E.M. (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9: pp. 179-186 CrossRef 13. Yesavage, J.A., Brink, T.L., Rose, T.L. (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17: pp. 37-49 CrossRef 14. Gage, B.F., Waterman, A.D., Shannon, W. (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285: pp. 2864-2870 CrossRef 15. Lip, G.Y.H., Nieuwlaat, R., Pisters, R. (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factorbased approach: the euro heart survey on atrial fibrillation. Chest 137: pp. 263-272 CrossRef 16. Gage, B.F., Yan, Y., Milligan, P.E. (2006) Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J 151: pp. 713-719 CrossRef 17. Lip, G.Y.H., Frison, L., Halperin, J.L. (2011) Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 57: pp. 173-180 CrossRef 18. Touze, E., Cambou, J., Ferrieres, J. (2005) Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies. Cerebrovasc Dis 20: pp. 78-84 CrossRef 19. Go, A.S., Hylek, E.M., Phillips, K.A. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: pp. 2370-2375 CrossRef 20. Ghaswalla, P.K., Harpe, S.E., Slattum, P.W. (2012) Warfarin use in nursing home residents: results from the 2004 national nursing home survey. Am J Geriatr Pharmacother 10: pp. 25-36 CrossRef 21. Nabauer, M., Gerth, A., Limbourg, T. (2009) The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace 11: pp. 423-434 CrossRef 22. Nieuwlaat, R., Capucci, A., Lip, G.Y.H. (2006) Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 27: pp. 3018-3026 CrossRef 23. Lip, G.Y.H., Laroche, C., Dan, G.A. (2014) 鈥楻eal-world鈥?antithrombotic treatment in atrial fibrillation: the EURObservational Research Programme Atrial Fibrillation General Pilot survey. Am J Med. 24. Cohen, A., Dallongeville, J., Durand-Zaleski, I. (2010) Characteristics and management of outpatients with history of or current atrial fibrillation: the observational French EPHA study. Arch Cardiovasc Dis 103: pp. 376-387 CrossRef 25. Kirchhof, P., Ammentorp, B., Darius, H. (2013) Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events鈥擡uropean Registry in Atrial Fibrillation (PREFER in AF). Europace. 26. Friberg, L., Hammar, N., Ringh, M. (2006) Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). Eur Heart J 27: pp. 1954-1964 CrossRef 27. Go, A.S., Hylek, E.M., Phillips, K.A. (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285: pp. 2370-2375 CrossRef 28. Hylek, E.M., Evans-Molina, C., Shea, C. (2007) Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 115: pp. 2689-2696 CrossRef 29. Kyriazi, V., Theodoulou, E. (2013) Assessing the risk and prognosis of thrombotic complications in cancer patients. Arch Pathol Lab Med 137: pp. 1286-1295 CrossRef 30. Mant, J.W.F., Richards, S.H., Hobbs, F.D.R. (2003) Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]. BMC Cardiovasc Disord 3: pp. 9 CrossRef 31. Moroney, J.T., Tseng, C.L., Paik, M.C. (1999) Treatment for the secondary prevention of stroke in older patients: the influence of dementia status. J Am Geriatr Soc 47: pp. 824-829
刊物主题:Geriatrics/Gerontology; Nutrition; Aging; Neurosciences; Primary Care Medicine; Quality of Life Research;